Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, confirming a novel approach for a more rapid diagnosis of heart attack in patients with acute ...

The current lower limit for detection of plasma troponin T in most commercially available tests is approximately 0.01 μg/l, and levels higher than this value are associated with increased mortality.

Please provide your email address to receive an email when new articles are posted on . Roche Diagnostics Corp. announced that the FDA has cleared its next-generation troponin T assay for use in ...

The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than ...

Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack. With this clearance, Roche is ...

High-sensitivity cardiac troponin assays may eventually play a part in an overall strategy for evaluating patients who present with stable chest pain symptoms and possible coronary disease, an ...

A modified algorithm using a high-sensitivity cardiac troponin T (hs-cTnT) assay safely and rapidly ruled out more patients with myocardial infarction in one US emergency department, with more than ...

A new study out of Sweden shows that a rapid test for a cardiac enzyme, when combined with a normal electrocardiogram, rules out a heart attack with 99.8 percent reliability. What are the implications ...

Cardiac troponin T is a protein biomarker detectable with a blood test, and it is the preferred biomarker for determining cardiovascular risk. In a new study published in JAMA Cardiology, researchers ...

Please provide your email address to receive an email when new articles are posted on . “Our study suggests that patients are routinely discharged from the ED after a single negative troponin test ...

PARIS — A single cardiac troponin measurement by high-sensitivity cardiac troponin I (hs-cTnI) assay can safely and effectively rule out myocardial infarction (MI) at presentation, results from more ...